NNMT inhibition addresses the deficit by preventing the enzyme (NNMT) that wastes the precursor from inside the cell
AOD-9604 primarily targets fat metabolism MOTS-c focuses on mitochondrial function and metabolic efficiency Tesamorelin increases physiologic growth hormone release and reduces visceral fat Semaglutide reduces appetite through GLP-1 signaling Tirzepatide combines GLP-1 and GIP receptor activation and currently delivers some of the most impressive weight-loss results seen in modern medicine Understanding these differences is essential when choosing the right therapy for weight loss, metabolic health, body composition, or long-term wellness goals
Our cycle planning guide helps you map out your full protocol - when to start, how long to run, when to assess progress, when to adjust
Unlike full-length growth hormone, AOD-9604 selectively targets fat metabolism through beta-3 adrenergic receptor pathways without affecting insulin sensitivity or IGF-1 levels
is essential for mitochondrial energy production, DNA repair, and numerous enzymatic reactions, researchers have investigated how modulation of NNMT activity may influence cellular bioenergetics and metabolic efficiency
The peptide does not act as a stimulant or affect the central nervous system in ways that impair sleep